Cand.med. Zhihui Wang from Ruth Holm's group at the Department of Pathology will give her trial lecture on Wednesday June 29nd at 10:15 on the subject "Molecular alterations in vulvar cancer. How can they be used to improve diagnosis and therapy?"
She will defend her PhD thesis - entitled "Prognostic significance of 14-3-3s and CDC25s in vulvar squamous cell carcinoma" at 13:15 the same day
Both events take place in the Auditorium BU1 at OUS-Radiumhospitalet (Montebello).
From major journals, first or last author from the Institute for Cancer Research
Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains
Oncogene (in press)
Finding Neo (antigens, that is)
Blood, 134 (2), 108-109
Biomarker-guided therapy for colorectal cancer: strength in complexity
Nat Rev Clin Oncol (in press)